Source: Annual Congress 2007 - Cost-effectiveness in diagnosis, therapy and care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bischof, J. Leuppi (Basel, Switzerland). Cost-effectiveness of eNO measurements in chronic asthma management. Eur Respir J 2007; 30: Suppl. 51, 1184

Member's Comments

No comment yet.

Related content which might interest you: Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children Source: Eur Respir J 2006; 28: Suppl. 50, 481s Year: 2006 The usefulness of the simultaneous measurement of IOS and FeNO in the management of asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 The use of omalizumab in the management of severe chronic paediatric asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 FENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma Source: Eur Respir J, 55 (5) 2001319; 10.1183/13993003.01319-2020 Year: 2020 Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Evaluation and management of difficult-to-control asthma Source: Annual Congress 2004 - PG12 - Asthma: from bench to bedside Year: 2004 Magnetocardiographic assessment of therapeutic efficacy of β2–agonists and corticosteroids in patients with COPD and bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Acute severe asthma: evidence-based management of asthma exacerbations Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond Year: 2008 Cost effectiveness of bronchial thermoplasty for treatment of severe asthma patients in spain Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Effects of ciclesonide on the management of stable COPD with airway eosinophilia Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Feasibility and acceptability of spirometry and FeNO testing in children treated for asthma in primary care Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Pharmacoeconomic aspects of inhaled corticocteroids in the treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Cost-effectiveness of budesonid/formoterol inhaler in treatment of moderate bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 Utility of high dose inhaled fluticasone therapy for the early management of acute exacerbations of asthma Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 Prevention and management of exacerbations of asthma and COPD Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care Year: 2010 Spirometry, FeNO, and asthma control in children managed for asthma in primary care Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care Year: 2019